Research shows cattle respect both electric and invisible boundaries, creating new opportunities for grazing management.

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Professor Lutz Ackermann from the University of Göttingen has been awarded a prize in the "Project of the Century" competition of the Werner Siemens Foundation (WSS). Ackermann's team and five others ...

Recognition for outstanding humanities research: Professor of Arabic and Islamic Studies, Irene Schneider and linguist Professor Hedde Zeijlstra from the University of Göttingen have each been awarded ...

An international research team led jointly by the University Medical Center Göttingen (UMG), the University of Göttingen and the University of Western Ontario in London, Canada, has shown that nerve ...

The University Medical Center Göttingen is one of Germany’s leading medical centers. With funding allocated by the state of Lower Saxony and third-party funding, we conduct research at the very ...

NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of enhanced, new-generation of Antibody Drug Conjugates (ADCs), today announces it has executed its option to secure ...

Göttingen’s motto “The city that creates knowledge” is emblazoned on the central train station where it welcomes newcomers and long-time residents alike. It could hardly be more fitting, given that ...

UK-based biotech company Iksuda Therapeutics has executed its option to secure exclusive worldwide rights to develop a new class of tumour-activated prodrug payloads from the University of Goettingen.

Regarded as one of the most prestigious universities in Germany, the University of Göttingen is located in the historic Saxon town of the same name, in the centre of Germany. Established in 1737, the ...

Iksuda Therapeutics (Iksuda), today announces it has executed its option to secure exclusive, worldwide rights to develop a novel class of tumour-activated prodrug payloads from the University of ...